Brief: Cardeon's Portfolio Co Prolight Announces Positive Data From Patient Blood Study At St Thomas' Hospital, London
16/06/2025 13:04
June 16 (Reuters) - Cardeon AB (publ) CARDEO.NGM: CARDEON'S PORTFOLIO COMPANY PROLIGHT ANNOUNCES POSITIVE DATA FROM PATIENT BLOOD STUDY AT ST THOMAS' HOSPITAL, LONDON Source text: ID:nMFNb5gvg0 Further company coverage: CARDEO.NGM (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Cardeon AB (publ)
See all newsBrief: Cardeon's Portfolio Co Prolight Announces Positive Data From Patient Blood Study At St Thomas' Hospital, London
Brief: Cardeon Signs Loi To Buy 25% Of Insunova Diagnostics
Brief: Tectona Capital H2 Net Loss Widens To SEK 4.8 Mln
Brief: Tectona H1 Operating Result Swings To Loss SEK 232,000
Brief: Tectona Capital: Bond Issue Subscribed For SEK 2,550,000